Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Danish National Lymphoma Registry: Coverage and Data Quality.
Arboe B, El-Galaly TC, Clausen MR, Munksgaard PS, Stoltenberg D, Nygaard MK, Klausen TW, Christensen JH, Gørløv JS, Brown Pde N. Arboe B, et al. Among authors: brown pde n. PLoS One. 2016 Jun 23;11(6):e0157999. doi: 10.1371/journal.pone.0157999. eCollection 2016. PLoS One. 2016. PMID: 27336800 Free PMC article.
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.
El-Galaly TC, Hutchings M, Mylam KJ, Brown Pde N, Bukh A, Johnsen HE, Kamper P, Loft A, Iyer V, Gormsen LC, Nielsen AL, Bøgsted M, d'Amore F. El-Galaly TC, et al. Among authors: brown pde n. Leuk Lymphoma. 2014 Oct;55(10):2349-55. doi: 10.3109/10428194.2013.875169. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24354682
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Møller MB, Nørgaard P, Johansen P, Ralfkiaer E, Brown Pde N, Hansen PB, Jensen BA, Madsen J, Schöllkopf C, d'Amore F. Pedersen MB, et al. Among authors: brown pde n. Hematol Oncol. 2015 Dec;33(4):120-8. doi: 10.1002/hon.2153. Epub 2014 Jul 23. Hematol Oncol. 2015. PMID: 25052551
Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study.
Mylam KJ, Michaelsen TY, Hutchings M, Jacobsen Pulczynski E, Pedersen LM, Braendstrup P, Gade IL, Eberlein TR, Gang AO, Bøgsted M, Brown PN, El-Galaly TC. Mylam KJ, et al. Br J Haematol. 2017 Feb;176(4):671-673. doi: 10.1111/bjh.13988. Epub 2016 Feb 23. Br J Haematol. 2017. PMID: 26913572 Free article. No abstract available.
Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study.
Jakobsen LH, Bøgsted M, Brown PN, Arboe B, Jørgensen J, Larsen TS, Juul MB, Schurmann L, Højberg L, Bergmann OJ, Lassen T, Josefsson PL, Jensen P, Johnsen HE, El-Galaly TC. Jakobsen LH, et al. J Clin Oncol. 2017 Mar;35(7):778-784. doi: 10.1200/JCO.2016.70.0765. Epub 2017 Jan 17. J Clin Oncol. 2017. PMID: 28095160
Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation.
Arboe B, Halgren Olsen M, Duun-Henriksen AK, Gørløv JS, Nielsen KF, Thomsen RH, Madsen C, Nielsen SR, Dalton SO, Brown PN. Arboe B, et al. Leuk Lymphoma. 2018 May;59(5):1153-1162. doi: 10.1080/10428194.2017.1369061. Epub 2017 Sep 4. Leuk Lymphoma. 2018. PMID: 28868963
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
Baech J, Hansen SM, Lund PE, Soegaard P, Brown PN, Haaber J, Jørgensen J, Starklint J, Josefsson P, Poulsen CB, Juul MB, Torp-Pedersen C, El-Galaly TC. Baech J, et al. Br J Haematol. 2018 Dec;183(5):717-726. doi: 10.1111/bjh.15603. Epub 2018 Nov 8. Br J Haematol. 2018. PMID: 30406945 Free article.
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.
35 results